APA (7th ed.) Citation

Wang, H., Wang, H., Li, Y., Zheng, B., Fang, Q., Li, Y., . . . Wang, J. (2025). Progression significance for low‐level aberrant B‐lymphoblasts in chronic myeloid leukaemia patients. Clinical & Translational Medicine, 15(11), 1. https://doi.org/10.1002/ctm2.70524

Chicago Style (17th ed.) Citation

Wang, Haoren, et al. "Progression Significance for Low‐level Aberrant B‐lymphoblasts in Chronic Myeloid Leukaemia Patients." Clinical & Translational Medicine 15, no. 11 (2025): 1. https://doi.org/10.1002/ctm2.70524.

MLA (9th ed.) Citation

Wang, Haoren, et al. "Progression Significance for Low‐level Aberrant B‐lymphoblasts in Chronic Myeloid Leukaemia Patients." Clinical & Translational Medicine, vol. 15, no. 11, 2025, p. 1, https://doi.org/10.1002/ctm2.70524.